The Food and Drug Administration yesterday issued an emergency use authorization allowing health care providers to administer the JYNNEOS vaccine intradermally to adults and subcutaneously to children at high risk for monkeypox infection, without an individual prescription for each vaccine recipient.

The Department of Health and Human Services has allocated almost 1.1 million doses of the vaccine to states and other jurisdictions, and has ordered another 5 million doses from the manufacturer for delivery this year and next. The FDA expects that allowing intradermal injection for adults will increase available doses by up to five fold.

HHS Secretary Xavier Becerra last week declared the monkeypox outbreak a public health emergency. The Centers for Disease Control and Prevention has reported almost 9,500 cases since the first U.S. case May 18. 

 

Related News Articles

Headline
The Department of Health and Human Services today renewed the nation’s monkeypox public health emergency declaration for another 90 days. When the PHE was…
Headline
As the monkeypox outbreak slows in the U.S., a new report from the Centers for Disease Control and Prevention highlights devastating outcomes of monkeypox for…
Headline
The Centers for Disease Control and Prevention today reported the first U.S. monkeypox case in a health care worker since the outbreak began in May. The report…
Headline
The Food and Drug Administration Friday authorized for emergency use the first commercial test kit to detect monkeypox in lesion swab specimens. Only…
Headline
Health and Human Services Secretary Xavier Becerra last week extended for 10 years his Aug. 4 public health emergency for monkeypox under the Public Readiness…
Headline
The Centers for Disease Control and Prevention yesterday recommended clinicians test all sexually active patients with monkeypox symptoms for HIV and other…